Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.862
-0.005 (-0.54%)
Nov 20, 2024, 4:00 PM EST - Market open
Carisma Therapeutics Stock Forecast
CARM's stock price has decreased by -65.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CARM stock have an average target of 12.67, with a low estimate of 6.00 and a high estimate of 24. The average target predicts an increase of 1,369.16% from the current stock price of 0.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CARM stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +2,682.93% | Nov 11, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +2,682.93% | Nov 7, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +2,682.93% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +827.64% | Jun 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +827.64% | Jun 26, 2024 |
Financial Forecast
Revenue This Year
22.44M
from 14.92M
Increased by 50.40%
Revenue Next Year
19.92M
from 22.44M
Decreased by -11.20%
EPS This Year
-1.25
from -2.59
EPS Next Year
-0.92
from -1.25
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.2M | 26.3M | 21.0M | ||
| Avg | 22.4M | 19.9M | 10.2M | ||
| Low | 19.0M | 13.3M | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 68.9% | 17.0% | 5.4% | ||
| Avg | 50.4% | -11.2% | -48.8% | ||
| Low | 27.4% | -40.6% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.18 | -0.60 | -0.62 | ||
| Avg | -1.25 | -0.92 | -0.63 | ||
| Low | -1.26 | -1.24 | -0.63 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.